MoneyWorks4Me

Colinz Laboratories - Quaterly Results

30 Jul 2022 Evaluate
The revenue declined to Rs. 18.38 millions for the quarter ended June 2022 as compared to Rs. 18.50 millions during the corresponding quarter last year.A comparatively good net profit growth of 32.53% to Rs. 1.10 millions was reported for the quarter ended June 2022 compared to Rs. 0.83 millions of previous same quarter.Operating profit surged to 1.87 millions from the corresponding previous quarter of 1.81 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 18.38 18.50 -0.65 18.38 18.50 -0.65 69.74 61.59 13.23
Other Income 0.41 0.41 0.00 0.41 0.41 0.00 1.71 1.91 -10.47
PBIDT 1.87 1.81 3.31 1.87 1.81 3.31 7.57 5.22 45.02
Interest 0.12 0.20 -40.00 0.12 0.20 -40.00 0.76 0.87 -12.64
PBDT 1.75 1.61 8.70 1.75 1.61 8.70 6.81 4.35 56.55
Depreciation 0.32 0.50 -36.00 0.32 0.50 -36.00 2.01 1.91 5.24
PBT 1.43 1.11 28.83 1.43 1.11 28.83 4.80 2.44 96.72
TAX 0.33 0.28 17.86 0.33 0.28 17.86 1.41 0.38 271.05
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.09 -0.40 -77.50
PAT 1.10 0.83 32.53 1.10 0.83 32.53 3.39 2.06 64.56
Equity 25.19 45.71 -44.89 25.19 45.71 -44.89 35.45 35.45 0.00
PBIDTM(%) 10.17 9.78 3.99 10.17 9.78 3.99 10.85 8.48 28.07
Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..